Luis Robles

574 total citations
32 papers, 333 citations indexed

About

Luis Robles is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Luis Robles has authored 32 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Luis Robles's work include Colorectal Cancer Treatments and Studies (14 papers), Genetic factors in colorectal cancer (11 papers) and Renal cell carcinoma treatment (4 papers). Luis Robles is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Genetic factors in colorectal cancer (11 papers) and Renal cell carcinoma treatment (4 papers). Luis Robles collaborates with scholars based in Spain, Portugal and Ecuador. Luis Robles's co-authors include Pilar García‐Alfonso, María Sanjurjo‐Sáez, Cristina Grávalos, Xandra García‐González, Luis A. López‐Fernández, María I. García, Vanessa Pachón, Susana Hernando, H. Cortés-Funes and Luis Paz‐Ares and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Luis Robles

31 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Robles Spain 10 235 96 74 62 46 32 333
Maro H. Sandel Netherlands 12 262 1.1× 63 0.7× 30 0.4× 57 0.9× 47 1.0× 15 508
İnci Yıldız Türkiye 13 68 0.3× 160 1.7× 32 0.4× 51 0.8× 25 0.5× 37 383
Myke R. Green United States 11 155 0.7× 81 0.8× 43 0.6× 38 0.6× 49 1.1× 24 396
Maham Hayat United States 11 92 0.4× 38 0.4× 39 0.5× 32 0.5× 45 1.0× 56 292
J Janssen Netherlands 7 182 0.8× 83 0.9× 14 0.2× 17 0.3× 35 0.8× 14 327
Yongyong Ma China 12 136 0.6× 84 0.9× 64 0.9× 40 0.6× 27 0.6× 33 316
Kana Yoshida Japan 10 82 0.3× 181 1.9× 62 0.8× 44 0.7× 35 0.8× 20 441
Lawrence Liu United States 10 62 0.3× 207 2.2× 23 0.3× 80 1.3× 54 1.2× 40 414
Chia‐Lin Chou Taiwan 11 117 0.5× 104 1.1× 44 0.6× 19 0.3× 65 1.4× 39 311
U Grützner Germany 7 183 0.8× 53 0.6× 16 0.2× 60 1.0× 32 0.7× 13 309

Countries citing papers authored by Luis Robles

Since Specialization
Citations

This map shows the geographic impact of Luis Robles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Robles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Robles more than expected).

Fields of papers citing papers by Luis Robles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Robles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Robles. The network helps show where Luis Robles may publish in the future.

Co-authorship network of co-authors of Luis Robles

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Robles. A scholar is included among the top collaborators of Luis Robles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Robles. Luis Robles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castillejo, Adela, Mercedes Robledo, Àlex Teulé, et al.. (2024). Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome. Orphanet Journal of Rare Diseases. 19(1). 26–26. 1 indexed citations
2.
Hoya, Miguel de la, et al.. (2023). Unexpected Findings in Hereditary Breast and Ovarian Cancer Syndrome: Low-Level Constitutional Mosaicism in BRCA2. Genes. 14(2). 502–502. 3 indexed citations
3.
Benavides, Manuel, Auxiliadora Gómez‐España, Pilar García‐Alfonso, et al.. (2021). Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). European Journal of Surgical Oncology. 48(5). 1123–1132. 3 indexed citations
4.
Santos, María, Javier Lanillos, Juan María Roldán‐Romero, et al.. (2021). Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma. Genetics in Medicine. 23(4). 698–704. 13 indexed citations
5.
García‐González, Xandra, Fabienne Thomas, Pilar García‐Alfonso, et al.. (2020). New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine. Cancer Chemotherapy and Pharmacology. 86(1). 45–54. 15 indexed citations
6.
Guillén‐Ponce, Carmen, et al.. (2020). SEOM clinical guideline on hereditary colorectal cancer (2019). Clinical & Translational Oncology. 22(2). 201–212. 10 indexed citations
7.
Perea, José, Soraia Melo, Fátima Mercadillo, et al.. (2018). Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer. European Journal of Human Genetics. 26(9). 1348–1353. 6 indexed citations
8.
García‐González, Xandra, María I. García, Pilar García‐Alfonso, et al.. (2018). Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan. Pharmacological Research. 136. 133–139. 19 indexed citations
9.
Grávalos, Cristina, Alfredo Carrato, Mercedes Rodríguez-Garrote, et al.. (2018). A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 17(2). e323–e329. 15 indexed citations
10.
Salazar, Ramón, Daniel Azuara, José María Viéitez, et al.. (2017). ULTRA clinical trial: Prospective comparative clinical outcome analysis of three different RAS/BRAF sensitivity mutational cut-offs. A Phase II study of the Spanish TTD Group. Annals of Oncology. 28. v185–v186. 1 indexed citations
11.
Pellicer, Marta, Xandra García‐González, María I. García, et al.. (2017). Identification of new SNPs associated with severe toxicity to capecitabine. Pharmacological Research. 120. 133–137. 39 indexed citations
12.
Pellicer, Marta, Xandra García‐González, María I. García, et al.. (2017). Use of Exome Sequencing to Determine the Full Profile of Genetic Variants in the Fluoropyrimidine Pathway in Colorectal Cancer Patients Affected by Severe Toxicity. Pharmacogenomics. 18(13). 1215–1223. 11 indexed citations
13.
Guillén‐Ponce, Carmen, Rafael Serrano del Rosal, Àlex Teulé, et al.. (2015). Clinical guideline seom: hereditary colorectal cancer. Clinical & Translational Oncology. 17(12). 962–971. 10 indexed citations
14.
García‐González, Xandra, María I. García, Pilar García‐Alfonso, et al.. (2015). Variants inCDAandABCB1are predictors of capecitabine-related adverse reactions in colorectal cancer. Oncotarget. 6(8). 6422–6430. 52 indexed citations
15.
Robles, Luis, et al.. (2014). Asociaciones público-privadas para servicio de salud: ¿la solución al sistema de salud peruano?. Revista Peruana de Medicina Experimental y Salud Pública. 31(4). 769–74. 5 indexed citations
16.
Repiso‐Jiménez, J.B., et al.. (2013). Cribado de neoplasia intraepitelial anal en grupos de riesgo: estudio descriptivo sobre hábitos sexuales y otras infecciones de transmisión sexual. Medicina Clínica. 142(4). 145–149. 2 indexed citations
17.
Perea, José, Iago Justo, José Díaz-Tasende, et al.. (2009). Surgical management of hereditary colorectal cancer: surgery based on molecular analysis and family history. Revista Española de Enfermedades Digestivas. 101(8). 536–40. 7 indexed citations
18.
Pereda, Teresa, et al.. (2007). Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma. Diagnostic Pathology. 2(1). 30–30. 4 indexed citations
19.
Jimeno, Antonio, Alberto Arcediano, Susana Bezares, et al.. (2006). Randomized Study of Cefepime versus Ceftazidime plus Amikacin in Patients with Solid Tumors Treated with High Dose Chemotherapy (HDC) and Peripheral Blood Stem Cell Support (PBSCS) with Febrile Neutropenia. Clinical & Translational Oncology. 8(12). 889–895. 4 indexed citations
20.
Jimeno, Antonio, Enrique González‐Billalabeitia, Susana Hernando, et al.. (2004). Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer. 100(11). 2462–2469. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maro H. Sandel Breakdown of academic impact, for papers by İnci Yıldız Breakdown of academic impact, for papers by Myke R. Green Breakdown of academic impact, for papers by Maham Hayat Breakdown of academic impact, for papers by J Janssen Breakdown of academic impact, for papers by Yongyong Ma Breakdown of academic impact, for papers by Kana Yoshida Breakdown of academic impact, for papers by Lawrence Liu Breakdown of academic impact, for papers by Chia‐Lin Chou Breakdown of academic impact, for papers by U Grützner
Rankless by CCL
2026